Supriya Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1985.
1985 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Supriya Pharmaceuticals Limited

Supriya Pharmaceuticals Limited, a active public limited company, was established on 24 July 1985 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U01100DL1985PLC445217. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.64 Cr.

It upholds a compliant status. Its leadership includes Manish Gupta (Nominee Director), Ramesh Dugar (Nominee Director), Yogesh Kumar (Nominee Director). Past directors included Hitesh Chopra, Chandrakure Parmeshwaram Madhu Kumar, Gagnish Arora. It holds ₹3.00 Cr open charges and ₹7.94 Cr settled loans. Its latest AGM occurred on 04 June 2025, with the balance sheet filed on 31 March 2025. It is based at 810, Arunachal Building, 19, Barkhamba Road, Connaught Place, New Delhi, Delhi, 110001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U01100DL1985PLC445217

  • Registration Number

    445217

  • Incorporation Date

    24 July 1985

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.64 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.64 Cr
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.00 Cr
  • Satisfied Charges ₹ 7.94 Cr
Company report

Supriya Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Supriya Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Supriya Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Manish Gupta Nominee Director 06 Feb 2024 Current
Ramesh Dugar Nominee Director 08 Feb 2012 Current
Yogesh Kumar Nominee Director 16 May 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 23 Jun 2009 Past
Pramod Abcsdd Director 08 Feb 2012 Past
Pramod Abcsdd Director 01 Dec 2007 Past
Pramod Abcsdd Director 06 Feb 2024 Past
Pramod Abcsdd Director 08 Feb 2012 Past
Pramod Abcsdd Managing Director 08 Feb 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supriya Pharmaceuticals.
Supriya Pharmaceuticals revenue growth over time
Supriya Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supriya Pharmaceuticals?

Unlock access to Supriya Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹30,000,000.00

Satisfied Charges

₹79,375,600.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 4.94 Cr
  • United Bank Of India : 3.00 Cr
Latest Charge Details
Date Lender Amount Status
22 Aug 2005 United Bank Of India ₹3.00 Cr Satisfied
21 Jan 1998 Canara Bank ₹0.30 M Satisfied
20 Aug 1992 Canara Bank ₹3.00 Cr Satisfied
31 Jan 1992 Canara Bank ₹3.00 M Satisfied
16 Aug 1991 Canara Bank ₹5.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Supriya Pharmaceuticals?

Unlock and access historical data on people associated with Supriya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Supriya Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supriya Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge registered on 22 Aug 2005 via Charge ID 90069297 with United Bank Of India was fully satisfied on 23 Sep 2025. was recorded as a recent event.

  • Annual General Meeting

    Progress on Supriya Pharmaceuticals Limited last Annual general meeting of members was held on 04 Jun 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Supriya Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Manish Gupta was appointed as a Nominee Director was appointed as a Nominee Director on 06 Feb 2024 & has been associated with this company since 2 years 15 days . was documented.

  • Director Appointment

    The activity Yogesh Kumar was appointed as a Nominee Director was appointed as a Nominee Director on 16 May 2017 & has been associated with this company since 8 years 9 months . was completed.

  • Director Appointment

    Ramesh Dugar was appointed as a Nominee Director was appointed as a Nominee Director on 08 Feb 2012 & has been associated with this company since 14 years 13 days . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Supriya Pharmaceuticals Limited?

The CIN of Supriya Pharmaceuticals Limited is U01100DL1985PLC445217.

Where is Supriya Pharmaceuticals Limited headquartered?

Supriya Pharmaceuticals Limited is headquartered at 810, Arunachal Building, 19, Barkhamba Road, Connaught Place, New Delhi, Delhi, 110001.

When was Supriya Pharmaceuticals Limited incorporated?

Supriya Pharmaceuticals Limited was incorporated on 24 July 1985.

Who are the current directors of Supriya Pharmaceuticals Limited?

The current directors of Supriya Pharmaceuticals Limited are

What is the primary industry of Supriya Pharmaceuticals Limited?

The primary industry of Supriya Pharmaceuticals Limited is Manufacturing.

Is Supriya Pharmaceuticals Limited a listed company?

Supriya Pharmaceuticals Limited is unlisted.

What is the capital structure of Supriya Pharmaceuticals Limited?

The authorized capital of Supriya Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹9.64 Cr.

What is the compliance status of Supriya Pharmaceuticals Limited?

The compliance status of Supriya Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available